Precision BioSciences Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
108
- Stock Symbol
-
DTIL
- Share Price
-
$5.14
- (As of Tuesday Closing)
Precision BioSciences General Information
Description
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Contact Information
Website
www.precisionbiosciences.comCorporate Office
- 302 East Pettigrew Street
- Durham, NC 27701
- United States
Corporate Office
- 302 East Pettigrew Street
- Durham, NC 27701
- United States
Precision BioSciences Stock Performance
As of 13-May-2025, Precision BioSciences’s stock price is $5.14. Its current market cap is $54.3M with 10.6M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.14 | $5.22 | $3.61 - $13.44 | $54.3M | 10.6M | 154K | $1.05 |
Precision BioSciences Financials Summary
As of 31-Dec-2024, Precision BioSciences has a trailing 12-month revenue of $68.7M.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | (41,668) | (41,668) | (53,872) | (52,551) |
| Revenue | 68,696 | 68,696 | 48,727 | 25,098 |
| EBITDA | 6,763 | 6,763 | (39,728) | (66,267) |
| Net Income | 7,167 | 7,167 | (61,319) | (111,637) |
| Total Assets | 136,388 | 136,388 | 159,781 | 238,169 |
| Total Debt | 30,045 | 30,045 | 31,268 | 24,960 |
Precision BioSciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Precision BioSciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Precision BioSciences Comparisons
Industry
Financing
Details
Precision BioSciences Competitors (70)
One of Precision BioSciences’s 70 competitors is Intellia Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Editas Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Caribou Biosciences | Formerly VC-backed | Berkeley, CA | ||||
| CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland | ||||
| Beam Therapeutics | Formerly VC-backed | Cambridge, MA |
Precision BioSciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Precision BioSciences Patents
Precision BioSciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4460334-A1 | Optimized polynucleotides for protein expression | Pending | 07-Jan-2022 | ||
| AU-2023205923-A1 | Optimized polynucleotides for protein expression | Pending | 07-Jan-2022 | ||
| US-20250064986-A1 | Optimized polynucleotides for protein expression | Pending | 07-Jan-2022 | ||
| US-20250041417-A1 | Methods for cancer immunotherapy | Pending | 10-Dec-2021 | ||
| US-20250009800-A1 | Methods for cancer immunotherapy | Pending | 16-Nov-2021 | A61K35/17 |
Precision BioSciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Precision BioSciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Precision BioSciences ESG
Risk Overview
Risk Rating
Updated July, 02, 2022
27.2 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,912
Rank
Percentile
Pharmaceuticals
Industry
of 965
Rank
Percentile
Biotechnology
Subindustry
of 443
Rank
Percentile
Precision BioSciences FAQs
-
When was Precision BioSciences founded?
Precision BioSciences was founded in 2006.
-
Where is Precision BioSciences headquartered?
Precision BioSciences is headquartered in Durham, NC.
-
What is the size of Precision BioSciences?
Precision BioSciences has 108 total employees.
-
What industry is Precision BioSciences in?
Precision BioSciences’s primary industry is Biotechnology.
-
Is Precision BioSciences a private or public company?
Precision BioSciences is a Public company.
-
What is Precision BioSciences’s stock symbol?
The ticker symbol for Precision BioSciences is DTIL.
-
What is the current stock price of Precision BioSciences?
As of 13-May-2025 the stock price of Precision BioSciences is $5.14.
-
What is the current market cap of Precision BioSciences?
The current market capitalization of Precision BioSciences is $54.3M.
-
What is Precision BioSciences’s current revenue?
The trailing twelve month revenue for Precision BioSciences is $68.7M.
-
Who are Precision BioSciences’s competitors?
Intellia Therapeutics, Editas Medicine, Caribou Biosciences, CRISPR Therapeutics, and Beam Therapeutics are some of the 70 competitors of Precision BioSciences.
-
What is Precision BioSciences’s annual earnings per share (EPS)?
Precision BioSciences’s EPS for 12 months was $1.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
